title: Synergistic Antiproliferative Effects of Combined γ -Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ -Independent Mechanisms in Breast Cancer Cells.
abstract: Previous findings showed that the anticancer effects of combined γ -tocotrienol and peroxisome proliferator activated receptor γ (PPAR γ ) antagonist treatment caused a large reduction in PPAR γ expression. However, other studies suggest that the antiproliferative effects of γ -tocotrienol and/or PPAR γ antagonists are mediated, at least in part, through PPAR γ -independent mechanism(s). Studies were conducted to characterize the role of PPAR γ in mediating the effects of combined treatment of γ -tocotrienol with PPAR γ agonists or antagonists on the growth of PPAR γ negative +SA mammary cells and PPAR γ -positive and PPAR γ -silenced MCF-7 and MDA-MB-231 breast cancer cells. Combined treatment of γ -tocotrienol with PPAR γ antagonist decreased, while combined treatment of γ -tocotrienol with PPAR γ agonist increased, growth of all cancer cells. However, treatment with high doses of 15d-PGJ2, an endogenous natural ligand for PPAR γ , had no effect on cancer cell growth. Western blot and qRT-PCR studies showed that the growth inhibitory effects of combined γ -tocotrienol and PPAR γ antagonist treatment decreased cyclooxygenase (COX-2), prostaglandin synthase (PGDS), and prostaglandin D2 (PGD2) synthesis. In conclusion, the anticancer effects of combined γ -tocotrienol and PPAR γ antagonists treatment in PPAR γ negative/silenced breast cancer cells are mediated through PPAR γ -independent mechanisms that are associated with a downregulation in COX-2, PGDS, and PGD2 synthesis.
authors.affiliation: College of Pharmacy, University of Louisiana at Monroe, 700 University Avenue, Monroe, LA 71209, USA.
authors.forename: Abhita
authors.identifier: 0000-0001-8027-5845
authors.initials: A
authors.lastname: Malaviya
authors.affiliation: College of Pharmacy, University of Louisiana at Monroe, 700 University Avenue, Monroe, LA 71209, USA.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Sylvester
references.citation: Int J Oncol. 2002 Jun;20(6):1109-22
references.pmid: 12011987
references.citation: Cell Prolif. 2006 Dec;39(6):563-74
references.pmid: 17109639
references.citation: Surg Today. 1998;28(7):740-5
references.pmid: 9697269
references.citation: Cell. 1995 Dec 1;83(5):813-9
references.pmid: 8521498
references.citation: In Vitro. 1979 Nov;15(11):841-3
references.pmid: 232056
references.citation: Exp Cell Res. 1994 Sep;214(1):145-53
references.pmid: 8082717
references.citation: Cancer Res. 2004 Aug 15;64(16):5592-6
references.pmid: 15313896
references.citation: Anticancer Res. 2011 Mar;31(3):813-23
references.pmid: 21498701
references.citation: Cancer Res. 1999 Jun 1;59(11):2739-46
references.pmid: 10364000
references.citation: Anticancer Res. 2004 Sep-Oct;24(5A):2765-71
references.pmid: 15517883
references.citation: Biomed Pharmacother. 2010 May;64(5):327-32
references.pmid: 19954924
references.citation: Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
references.pmid: 388439
references.citation: Cancer Res. 1980 Jun;40(6):1812-9
references.pmid: 7371012
references.citation: J Biol Chem. 2001 Oct 12;276(41):37731-4
references.pmid: 11459852
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: Lipids. 1995 Dec;30(12):1139-43
references.pmid: 8614304
references.citation: Mol Nutr Food Res. 2005 Jan;49(1):7-30
references.pmid: 15580660
references.citation: PPAR Res. 2008;2008:494161
references.pmid: 18779871
references.citation: PPAR Res. 2008;2008:326915
references.pmid: 18615182
references.citation: J Surg Oncol. 2001 Jan;76(1):26-30
references.pmid: 11223821
references.citation: Clin Cancer Res. 2001 Feb;7(2):429-34
references.pmid: 11234900
references.citation: Cell Prolif. 2010 Feb;43(1):77-83
references.pmid: 19922488
references.citation: Mol Cancer. 2008 Dec 05;7:90
references.pmid: 19061500
references.citation: PPAR Res. 2012;2012:968040
references.pmid: 23213321
references.citation: Int J Breast Cancer. 2013;2013:101705
references.pmid: 23431460
references.citation: Front Biosci (Landmark Ed). 2011 Jun 01;16:3183-95
references.pmid: 21622228
references.citation: Proc Soc Exp Biol Med. 2000 Sep;224(4):292-301
references.pmid: 10964265
references.citation: J Lipid Res. 2002 Nov;43(11):1818-28
references.pmid: 12401880
references.citation: Cancer Res. 1999 Mar 1;59(5):987-90
references.pmid: 10070951
references.citation: PPAR Res. 2010;2010:
references.pmid: 20814439
references.citation: Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:375-82
references.pmid: 12432930
references.citation: J Pharm Pharm Sci. 2004 Oct 29;7(3):332-6
references.pmid: 15576013
references.citation: Cancer Res. 2009 Aug 15;69(16):6565-72
references.pmid: 19638577
references.citation: Nat Med. 2001 Jan;7(1):48-52
references.pmid: 11135615
references.citation: Front Biosci. 2005 Jan 01;10:699-709
references.pmid: 15569611
references.citation: Chem Biol. 1995 May;2(5):261-6
references.pmid: 9383428
references.citation: Mol Nutr Food Res. 2010 Mar;54(3):345-52
references.pmid: 19866471
references.citation: J Pharmacol Exp Ther. 2001 Sep;298(3):865-72
references.pmid: 11504778
references.citation: Cell. 1995 Dec 1;83(5):803-12
references.pmid: 8521497
references.citation: Neoplasia. 2005 Mar;7(3):280-93
references.pmid: 15799828
references.citation: Gene. 2008 Dec 15;426(1-2):72-80
references.pmid: 18817855
references.citation: Mol Nutr Food Res. 2008 Aug;52(8):921-9
references.pmid: 18481320
references.citation: Endocr Relat Cancer. 2006 Jun;13(2):401-13
references.pmid: 16728570
references.citation: Lipids. 2000 Feb;35(2):171-80
references.pmid: 10757548
references.citation: Lipids. 1998 May;33(5):461-9
references.pmid: 9625593
references.citation: Clin Immunol. 2005 Feb;114(2):100-9
references.pmid: 15639643
references.citation: Biochem J. 1998 Aug 15;334 ( Pt 1):189-95
references.pmid: 9693119
references.citation: J Bioanal Biomed. 2011 Jan 10;3:1-7
references.pmid: 22140606
references.citation: Nihon Naibunpi Gakkai Zasshi. 1986 Aug 20;62(8):857-66
references.pmid: 3465609
references.citation: Int J Mol Med. 2013 Apr;31(4):778-88
references.pmid: 23403520
references.citation: Postgrad Med J. 2007 Jun;83(980):414-9
references.pmid: 17551074
references.citation: Free Radic Biol Med. 2011 May 15;50(10):1344-54
references.pmid: 21335085
references.citation: BMC Cancer. 2010 Mar 08;10:84
references.pmid: 20211018